Jubilant Life Sciences
JUBILANT.BO- 1D
- +0.9%
Jubilant Life Sciences in brief
Jubilant Life Sciences is a listed company in the Pharmaceutical industry, based in India. It was founded in 1978. Its market value was $1.6 B on 20 November 2026, which makes it the 7,259th largest listed company in the world and the 469th largest in India on this site. It employs about 2,554 people. Its shares trade under the symbol JUBILANT.BO (BSE).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Jubilant Life Sciences timeline
- 1978
- 🏁Founded
- 2003
- 📈Listed on National Stock Exchange of India as JUBLPHARMAFirst day of listing in the exchange's official list.
Events of Jubilant Life Sciences from Wikidata and the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Jubilant Life Sciences share price · NSE (JUBLPHARMA.NS)
Also priced on: NSE (JUBILANT.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 936.60 | 944.95 | 921.20 | 935.05 | +0.2% | 163,615 |
| Nov 19, 2026 | 933.00 | 937.75 | 914.00 | 933.25 | -0.0% | 191,837 |
| Nov 18, 2026 | 949.95 | 953.90 | 931.00 | 933.60 | -2.2% | 135,312 |
| Nov 17, 2026 | 970.00 | 987.00 | 942.70 | 954.50 | -0.6% | 193,212 |
| Nov 16, 2026 | 950.00 | 1,001 | 927.95 | 960.25 | -0.4% | 282,886 |
| Nov 13, 2026 | 976.50 | 982.20 | 960.80 | 964.10 | -1.9% | 54,761 |
| Nov 12, 2026 | 993.00 | 999.50 | 971.60 | 982.95 | -0.5% | 60,858 |
| Nov 11, 2026 | 976.30 | 993.80 | 967.00 | 987.50 | +2.2% | 103,221 |
| Nov 9, 2026 | 942.95 | 975.00 | 933.85 | 966.00 | +2.8% | 112,791 |
| Nov 6, 2026 | 946.00 | 954.40 | 934.10 | 939.60 | -0.8% | 58,214 |
| Nov 5, 2026 | 945.30 | 953.95 | 927.95 | 947.05 | +0.8% | 77,380 |
| Nov 4, 2026 | 940.00 | 953.00 | 933.00 | 939.55 | +0.1% | 50,216 |
| Nov 3, 2026 | 949.00 | 956.00 | 936.05 | 938.75 | -0.8% | 46,594 |
| Nov 2, 2026 | 925.00 | 949.90 | 919.00 | 946.75 | +2.5% | 148,076 |
| Oct 30, 2026 | 946.00 | 951.80 | 920.00 | 923.80 | -2.3% | 56,229 |
| Oct 29, 2026 | 943.90 | 956.10 | 937.30 | 946.00 | +0.2% | 45,198 |
| Oct 28, 2026 | 953.30 | 959.80 | 936.40 | 943.90 | -1.7% | 57,068 |
| Oct 27, 2026 | 939.80 | 965.90 | 931.40 | 959.80 | +2.4% | 143,473 |
| Oct 26, 2026 | 938.30 | 941.30 | 918.00 | 937.00 | -0.1% | 81,042 |
| Oct 23, 2026 | 932.00 | 944.80 | 895.10 | 938.30 | +0.7% | 142,183 |
| Oct 22, 2026 | 928.00 | 944.80 | 913.00 | 932.20 | +0.3% | 107,635 |
| Oct 21, 2026 | 938.20 | 938.50 | 911.60 | 929.40 | -0.7% | 177,629 |
| Oct 19, 2026 | 931.60 | 948.40 | 931.50 | 935.80 | -0.3% | 80,672 |
| Oct 16, 2026 | 938.20 | 954.90 | 928.60 | 938.60 | +0.0% | 134,966 |
| Oct 15, 2026 | 939.90 | 949.00 | 919.70 | 938.20 | -0.1% | 208,268 |
| Oct 14, 2026 | 945.00 | 948.90 | 928.50 | 938.90 | -0.4% | 391,864 |
| Oct 13, 2026 | 956.20 | 956.30 | 921.40 | 942.50 | -0.9% | 457,491 |
| Oct 12, 2026 | 931.90 | 969.90 | 908.00 | 950.90 | +2.0% | 1.4 M |
| Oct 9, 2026 | 940.40 | 950.00 | 917.60 | 931.90 | -0.0% | 123,186 |
| Oct 8, 2026 | 971.00 | 974.60 | 921.50 | 932.20 | — | 417,017 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Jubilant Life Sciences share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #253 (Jan 2020) · #216 (Jan 2021) · #450 (Dec 2022) · #456 (Nov 2026) · #464 (Nov 2026) · #458 (Nov 2026) · #461 (Nov 2026) · #471 (Nov 2026) · #471 (Nov 2026) · #467 (Nov 2026)
Mutual funds holding Jubilant Life Sciences#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors | 935,532 | $10 M | — | <0.01% | +0.0% | May 31, 2026 |
| 🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc. | 997,284 | $10 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc. | 939,993 | $9 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 678,091 | $7 M | — | 0.02% | no change | Jul 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Small Cap FundAditya Birla Sun Life AMC | 500,687 | $5 M | — | 0.79% | no change | Oct 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 405,731 | $4 M | — | 0.03% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc. | 265,623 | $3 M | — | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 234,336 | $2 M | — | 0.07% | no change | Jul 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal Asset Management | 214,139 | $2 M | — | 0.92% | −1.9% | Oct 31, 2026 |
| 🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors | 164,384 | $2 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc. | 135,019 | $1 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors | 128,534 | $1 M | — | 0.21% | −6.5% | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 107,093 | $1 M | — | <0.01% | +3.9% | May 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Bal Bhavishya YojnaAditya Birla Sun Life AMC | 105,213 | $1 M | — | 0.83% | no change | Oct 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 96,248 | $1 M | — | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 64,837 | $1 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla Sun Life AMC | 63,087 | $1 M | — | 0.54% | no change | Oct 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 54,860 | $1 M | — | <0.01% | +9.0% | Jul 31, 2026 |
| 🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC | 54,588 | $1 M | — | <0.01% | −5.6% | Jul 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 49,061 | $1 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 42,459 | $0 M | — | 0.06% | −2.9% | Jun 30, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP | 39,990 | $0 M | — | 0.02% | +2.6% | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 38,624 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 29,820 | $0 M | — | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 WisdomTree India Earnings FundWisdomTree Asset Management, Inc. | 24,309 | $0 M | — | 0.01% | −5.6% | Jun 30, 2026 |
As of Oct 31, 2026
Where Jubilant Life Sciences operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Jubilant Life Sciences: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇮🇳 India | Headquarters1 office | — |
FDA drug approvals: Jubilant Life Sciences#
56 approved applications held; 2 approvals and 0 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-08-17 | TadalafilTadalafil · ANDA210592 | Generic drug (ANDA) |
| 2026-05-15 | TadalafilTadalafil · ANDA210329 | Generic drug (ANDA) |
| 2025-08-05 | BumetanideBumetanide · ANDA212470 | Generic drug (ANDA) |
| 2025-08-04 | Eslicarbazepine AcetateEslicarbazepine Acetate · ANDA211219 | Generic drug (ANDA) |
| 2025-05-20 | PregabalinPregabalin · ANDA209530 | Generic drug (ANDA) |
| 2025-04-15 | RanolazineRanolazine · ANDA211361 | Generic drug (ANDA) |
| 2025-04-11 | DeferasiroxDeferasirox · ANDA211660 | Generic drug (ANDA) |
| 2025-03-18 | PerphenazinePerphenazine · ANDA213694 | Generic drug (ANDA) |
| 2025-03-06 | Sildenafil CitrateSildenafil Citrate · ANDA202954 | Generic drug (ANDA) |
| 2025-03-03 | Oseltamivir PhosphateOseltamivir Phosphate · ANDA213695 | Generic drug (ANDA) |
| 2024-12-20 | Sildenafil CitrateSildenafil Citrate · ANDA201156 | Generic drug (ANDA) |
| 2024-12-06 | Lurasidone HydrochlorideLurasidone Hydrochloride · ANDA210388 | Generic drug (ANDA) |
| 2024-10-02 | Solifenacin SuccinateSolifenacin Succinate · ANDA205484 | Generic drug (ANDA) |
| 2023-11-09 | Technetium Tc-99M Sulfur Colloid KitTechnetium Tc-99M Sulfur Colloid Kit · ANDA213516 | Generic drug (ANDA) |
| 2018-05-14 | NiacinNiacin · ANDA209156 | Generic drug (ANDA) |
| 2018-02-07 | Amantadine HydrochlorideAmantadine Hydrochloride · ANDA210403 | Generic drug (ANDA) |
| 2018-01-29 | Clonidine HydrochlorideClonidine Hydrochloride · ANDA210338 | Generic drug (ANDA) |
| 2017-12-26 | Draximage Dtpanew useTechnetium Tc-99M Pentetate Kit · NDA018511 (SUPPL-28) | New drug (NDA) |
| 2017-08-25 | IndomethacinIndomethacin · ANDA205215 | Generic drug (ANDA) |
| 2017-08-17 | Drax ExametazimeTechnetium Tc-99M Exametazime Kit · NDA208870 | New drug (NDA) |
| 2017-08-04 | Tizanidine HydrochlorideTizanidine Hydrochloride · ANDA209605 | Generic drug (ANDA) |
| 2017-06-30 | Bupropion HydrochlorideBupropion Hydrochloride · ANDA207459 | Generic drug (ANDA) |
| 2017-05-15 | Amlodipine And Olmesartan MedoxomilAmlodipine Besylate, Olmesartan Medoxomil · ANDA207450 | Generic drug (ANDA) |
| 2017-04-24 | Olmesartan MedoxomilOlmesartan Medoxomil · ANDA205482 | Generic drug (ANDA) |
| 2017-04-04 | CelecoxibCelecoxib · ANDA207061 | Generic drug (ANDA) |
Discuss Jubilant Life Sciences#
1 automatic updates and 0 member comments. Sign in to comment and react.
- Mutual funds: 45 funds hold $65 millionautomatic update · Oct 31, 2026
45 mutual funds in 2 countries hold shares of Jubilant Life Sciences worth $65 million (funds' newest reports, up to 31 October 2026). Since their previous reports 8 funds added shares and 10 sold; on balance they sold $32 million. Share splits are not counted as trading.
How Jubilant Life Sciences compares in Pharmaceutical
- Market cap$1.6 B · higher than 65% of 393
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Jubilant Life Sciences🇮🇳 | $1.6 B | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
How current the figures are
- Market cap:
- Nov 20, 2026
- Employees:
- As on March 2020
- Profile updated:
- Nov 22, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Jubilant Life Sciences? Verify and update this profile — free
Show Jubilant Life Sciences's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.